(Q73816366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

V Arolt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Rothermundt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K P Wandinger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Kirchner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

150-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.mp.4000650

6 November 2019

exact match

0 references

cites work

Autoimmunity in schizophrenia: a review of recent findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Cytokines and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Decreased production of interleukin-2 in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Electrocardiographic effects of amitriptyline in therapeutic doses on 24-hr monitoring (Holter) with correlation to plasma levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Serum interferon in patients with psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Serum Interferon in First Psychotic Attack

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Production of interferon-alpha and gamma by leukocytes from patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Cytokines production in chronic schizophrenia patients with or without paranoid behaviour.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

A whole-blood technique for testing production of human interferon by leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Production of cytokines in acute schizophrenic psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Production of interferon-gamma in families with multiple occurrence of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Acquired defect in interleukin-2 production in patients with type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Association of in vitro immune functions with the severity of the disease in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Modulation of the IL-2 production defect in vitro in Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interferon-gamma independently activates the MHC class I antigen processing pathway and diminishes glucose responsiveness in pancreatic beta-cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Is interleukin 2 a neuromodulator in the brain?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Circumscribed lesion of the medial forebrain bundle area causes structural impairment of lymphoid organs and severe depression of immune function in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Valid estimation of IL2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL2 consumption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Immunological dysfunction in schizophrenia: a systematic approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Short and long-term immunosuppressive effects of clozapine and haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Changes of immunological functions after acute exacerbation in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Nocturnal plasma levels of cytokines in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Effects of sleep on the production of cytokines in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000650

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822342%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference